Both Parents' Pre-Pregnancy Weight Shapes Fatty Liver Risk in Their Children, U.K. Data Shows

Fatty liver disease in children and young adults has grown substantially in prevalence over recent decades, tracking the global rise in overweight and obesity. What drives that risk is increasingly clear in broad terms - too much fat accumulation in liver cells, driven by metabolic imbalances - but pinning down when and where preventive intervention matters most has been harder to establish. A study using the UK Avon Longitudinal Study of Parents and Children (ALSPAC) offers a more precise answer: the influence begins before a child is born, in the weight of both parents before conception.

How the study was structured

Researchers followed 1,933 children from before birth to age 24, when liver fat was assessed using established metabolic criteria. Metabolic dysfunction-associated steatotic liver disease (MASLD, recently renamed from non-alcoholic fatty liver disease) was defined as elevated liver fat combined with at least one cardiometabolic risk factor - high cholesterol or high fasting glucose, for example.

Both parents provided pre-pregnancy height and weight, allowing calculation of body mass index before conception. Parents also completed regular questionnaires on smoking, alcohol use, employment, education, and other potentially influential factors throughout pregnancy and after delivery. The children's own BMI was measured at ages 7 to 9, 10 to 12, and 13 to 17, providing a picture of weight trajectory across childhood and adolescence.

By age 24, 201 of the 1,933 young adults (approximately 10%) had developed MASLD. Those with fatty liver disease were more likely to be male and to have had a higher childhood BMI. The other 1,732 had normal liver function.

The independent roles of maternal and paternal weight

Previous research on parental weight and offspring liver disease has focused heavily on maternal obesity, partly because the mechanisms of intrauterine influence are more obvious - the fetus develops in the mother's body and is directly exposed to her metabolic environment. Paternal influence is less studied and less mechanistically understood.

The ALSPAC analysis found both parents contribute independently. Each additional unit of maternal BMI before pregnancy was associated with a 10% increase in the odds of the child developing MASLD by age 24. Each equivalent unit of paternal pre-pregnancy BMI was associated with a 9% increase. The similarity of the two figures is notable: the mother's metabolic state before conception and the father's are roughly equally predictive of the child's outcome a quarter century later.

When both parents were overweight or obese before conception, the child's odds of developing MASLD by age 24 were more than three times higher than for children whose parents had normal pre-pregnancy BMI. That is a substantial effect size for an observational study, and it persisted after statistical adjustment for multiple potentially confounding factors including maternal diabetes history, alcohol use, smoking, and socioeconomic status.

The childhood years as the primary transmission pathway

Two-thirds (67%) of the association between parental pre-pregnancy weight and offspring MASLD was mediated by the child's own cumulative BMI between ages 7 and 17. In other words, parental weight before birth appears to influence the child's weight trajectory during childhood, and it is that childhood weight accumulation - not a direct intrauterine or genetic effect alone - that accounts for most of the elevated liver disease risk.

Supplementary analyses accounting for sugar consumption and genetic predisposition to MASLD produced similar results, suggesting the mediation effect is not simply capturing dietary patterns or inherited genetic risk.

What the findings do not establish

This is an observational cohort study. Observational designs cannot prove causation; they identify associations. The parental BMI data were self-reported rather than measured, introducing potential inaccuracy. The study had no information on parental MASLD status, which would be useful for disentangling genetic from environmental transmission. Children's physical activity levels in early adulthood were also not captured, which could independently influence liver fat accumulation.

The mechanisms by which paternal pre-pregnancy weight influences offspring liver health remain poorly understood. Epigenetic modifications in sperm are one candidate pathway - evidence from animal models suggests paternal diet and weight affect offspring metabolic programming through epigenetic marks - but this has not been established in humans.

Clinical implications

MASLD affects an estimated 15% of children and more than 30% of adults globally. It is the most common chronic liver disease worldwide and a precursor to cirrhosis and liver failure in a minority of affected individuals. The ALSPAC findings suggest that interventions targeting weight in both prospective parents before conception could have benefits that extend to their children's metabolic health over decades. "Efforts to mitigate excess adiposity of both mothers and fathers before conceiving may confer longitudinal benefits to the metabolic outcomes of their future offspring," the researchers conclude.